Bleeding Characteristics Of Patients With Congenital Haemophilia And Inhibitors: Data From A Postmarketing Study Of Recombinant Activated Factor VII (SMART-7)

Basit Öğe Kaydı
dc.contributor.authorKavakli, K.
dc.contributor.authorDemartis, F.
dc.contributor.authorBenson, G.
dc.contributor.authorCepo, K.
dc.contributor.authorChambost, H.
dc.contributor.authorBatorova, A.
dc.contributor.authorZak, M.
dc.date.accessioned2019-10-27T11:10:59Z
dc.date.available2019-10-27T11:10:59Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description.sponsorshipNovo NordiskNovo Nordisk; Baxalta; BayerBayer AG; PfizerPfizeren_US
dc.description.sponsorshipK. Kayakli Grant/Research support from: Novo Nordisk, Baxalta, Bayer, Pfizer, Consultant for: Novo Nordisk, Baxalta, Bayer, Pfizer, F. Demartis: None declared, G. Benson: None declared, K. Cepo Employee of: Novo Nordisk A/S, H. Chambost Grant/Research support from: Novo Nordisk, Consultant for: Bayer, Baxalta, CSL Bchring, Novo Nordisk, Pfizer, A. Batorova Grant/Research support from: Novo Nordisk, M. Zak Employee of: Novo Nordisk A/S.en_US
dc.identifier.endpage91en_US
dc.identifier.issn1351-8216
dc.identifier.issn1365-2516
dc.identifier.startpage91en_US
dc.identifier.urihttps://hdl.handle.net/11454/32452
dc.identifier.volume23en_US
dc.identifier.wosWOS:000393554500146en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHaemophiliaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleBleeding Characteristics Of Patients With Congenital Haemophilia And Inhibitors: Data From A Postmarketing Study Of Recombinant Activated Factor VII (SMART-7)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu